By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.

Delivering on the Promise of Synthetic Data

Meet the Replica Analytics Team

Our team brings deep expertise as well as decades of international experience in machine learning, privacy protection, data analysis, and building successful businesses that serve large global clients.

Dr. Khaled El Emam, CEO

Dr. Khaled El Emam is a co-founder and CEO of Replica Analytics.  As an entrepreneur, Khaled has founded or co-founded five other companies involved with data management and data analytics. He has worked in technical and management positions in academic and business settings in England, Scotland, Germany, Japan, and Canada.

Khaled is also a senior scientist at the Children’s Hospital of Eastern Ontario (CHEO) Research Institute and Director of the multi-disciplinary Electronic Health Information Laboratory, conducting applied research on data synthesis, and the identifiability of health information and how to measure it. He is a Canada Research Chair (Tier 1) in Medical AI and a Professor at the School of Epidemiology and Public Health in the Faculty of Medicine, University of Ottawa.

In 2003 and 2004, Dr. Khaled El Emam was ranked as the top systems and software engineering scholar worldwide by the Journal of Systems and Software based on his research on measurement and quality evaluation and improvement.

Previously, Khaled was a Senior Research Officer at the National Research Council of Canada. He also served as the head of the Quantitative Methods Group at the Fraunhofer Institute in Kaiserslautern, Germany.

Dr. Khaled El Emam held the Canada Research Chair in Electronic Health Information at the University of Ottawa from 2005-2015. He has a Ph.D. from the Department of Electrical and Electronics Engineering, King’s College, at the University of London, England.


Lucy Mosquera, Director of Data Science

Lucy Mosquera has a background in biology and mathematics, having done her studies at Queen's University in Kingston and the University of British Columbia. In the past she has provided data management support to clinical trials and observational studies at Kingston General Hospital. She also worked on clinical trial data sharing methods based on homomorphic encryption and secret sharing protocols with various companies.

At Replica Analytics, Lucy is responsible for integrating her subject area expertise in health data into innovative methods for synthetic data generation and the assessment of that data, as well as overseeing our analytics program.


Ash Kamath, Director of Global Sales

Ash Kamath leads Replica Analytic's sales activities worldwide and is an accomplished software executive (SaaS and on-premise) with a 15-year proven track record in driving significant growth, gaining market share and over-achieving target goals in startups, venture-backed and public companies.

Ash takes a consultative, customer-centric approach with a strong emphasis on relationship building. He understands his client's business challenges and the industry and market dynamics that affect their business.

With a technical background in Electrical Engineering and Computer Science, Ash embraces a steep learning curve and technology that would be considered game-changers in its industry.

Before joining Replica Analytics, Ash Kamath worked with several of the top 50 pharmaceutical companies at Systech International in Princeton, New Jersey, growing their serialization, track-and-trace and anti-counterfeiting business to a successful acquisition in 2020.


Sheldon Stevens, CFO

Sheldon Stevens is the Chief Financial Officer at Replica Analytics. He started his career with Ernst & Young’s accounting and management consulting groups before joining Husky Injection Molding Systems.  In 1995, Sheldon joined Deloitte Consulting, where he managed projects within both the Value-Based Management and Change Leadership service lines. 

Sheldon Stevens was a founding shareholder of VOCI, a voice response company based in Silicon Valley as well as UnCommon grounds, a chain of coffee shops.

Over the past 19 years, Sheldon Stevens has been the Chief Financial Officer for over 30 companies including, DNA Genotek, Privacy Analytics, Risk Sciences International, bluArc Communications, Embotics Corporation, Decisive Technologies Inc. and Britesky Technologies Inc. 

Sheldon has repeatedly worked with founders and entrepreneurs to help grow their ideas into companies and on to successful exits for all shareholders. Sheldon Stevens has sat on the board of HireTopTalent Inc, Network Planning Systems, IPeak Networks (now LiveQOS), MyHealth Interactive Magazine and Agent App.


Dr. Richard Hoptroff, NED

Richard Hoptroff is a long term technology inventor, investor and entrepreneur. Awarded a Ph.D. in Physics by King’s College London for his work in optical computing and artificial intelligence.  In 1992, he co-founded Right Information Systems, a neural net forecasting software company that was later sold to Cognos Inc (part of IBM).

He then worked as a postdoc at the Research Laboratory for Archaeology and the History of Art at Oxford University and in 2001, created Flexipanel Ltd, a company supplying Bluetooth modules to the electronics industry.

In 2010, he founded Hoptroff London, with the aim to develop smart, hyper-accurate watch movements and create a new watch brand. In 2013 Richard Hoptroff established a new commercial category when he brought to market the first commercial atomic timepiece and an atomic wristwatch.

Richard Hoptroff then leveraged his expertise in timing technology and software to develop a hyper-accurate synchronized timestamping solution for the financial services sector, based on a unique combination of grandmaster atomic clock engineering and proprietary software.